Here’s the Scoop: Fun Facts for National Ice Cream Day
When President Ronald Reagan in 1984 designated the month of July as National Ice Cream Month and declared the third Sunday of July as National Ice Cream Day, he probably never could have foreseen a time when flavors of the treat included Pork Rind, Strawberry Durian or Squid.
Ice cream shops around the country will be celebrating their special day again this Sunday, July 19. Carvel stores will be offering a buy-one-get-one-free deal on any size or flavor of soft-serve cones. Friendly’s is celebrating its 80th birthday this weekend, with participating stores also offering buy-one-get-one-free deals. Baskin-Robbins is offering a free upgrade to waffle cones with double scoops during the entire month of July. It also will offer 31 percent off all its ice cream sundaes on Friday, July 31.
Related: Born in the USA: 24 Iconic American Foods
Those chains offer a wide variety of flavors, but probably nothing quite as exotic as the OddFellows Ice Cream Co. in New York City, known for formulations loaded with unusual ingredients: Edamame, Chorizo Caramel Swirl, Cornbread and Maple Bacon Pecan. OddFellows co-owner Mohan Kumar says National Ice Cream Day will be just a regular Sunday for him and his stores: “It’s a beautiful day for ice cream every day.”
As you consider indulging in a frozen snack, here are some fun facts to fuel our red hot passion for ice cream:
Who Screams for Ice Cream: California, Indiana, Pennsylvania, Texas and New York are the states that consume the most ice cream. California also produces the most ice cream—over 142,000 gallons every year. About 10.3 percent of all the milk produced by U.S. dairy farmers is used to make ice cream. The five most popular brands in the U.S. are private labels, followed by Blue Bell, Haagen-Dazs, Breyers and Ben & Jerry’s. According to the International Dairy Foods Association, vanilla is America’s favorite flavor of ice cream, followed by chocolate. And how’s this for being ice cream crazy? Ben & Jerry’s employees get three free pints a day. They also get a free gym membership.
Hard Facts About Soft Serve: Despite many headlines to the contrary, it does not look like former British Prime Minister Margaret Thatcher invented soft-serve ice cream before she became known as the Iron Lady. The honor instead goes to Tom Carvel of Carvel ice cream or Dairy Queen co-founder J. F. McCullough. In Carvel’s case, his ice cream truck got a flat tire in Hartsdale, New York, in 1934. As the ice cream started to melt, he noticed its soft, creamy consistency and began selling it right from the truck. Two years later, he opened his first Carvel shop at the site where the truck first broke down.
Related: The 9 Most Expensive Junk Foods
Why We’re All Coneheads: Italo Marchiony, an Italian immigrant, was granted a patent for waffle-like ice cream cups in New York City in December 1903. But he may not be the father of the cones we enjoy today. As the story goes, Arnold Fornachou, an ice cream vendor at the 1904 World’s Fair in St. Louis, ran out of dishes. His neighbor, a Syrian man, was selling crisp, Middle Eastern pastries called Zalabias. When rolled up, the waffle-like Zalabias made a perfect cone to hold the ice cream. The International Association of Ice Cream Manufacturers and the International Dairy Foods Association credit Ernest A. Hamwi, the pastry maker, with creating the cone, but others have also claimed credit — including Abe Doumar, another Syrian immigrant at the 1904 fair who would go on to produce the first machine to mass-produce ice cream waffle cones.
Chart of the Day: High Deductible Blues
The higher the deductible in your health insurance plan, the less happy you probably are with it. That’s according to a new report on employer-sponsored health insurance from the Kaiser Family Foundation and the Los Angeles Times.
Chart of the Day: Tax Cuts and the Missing Capex Boom
Despite the Republican tax overhaul, businesses aren’t significantly increasing their capital expenditures. “The federal government will have to borrow an added $1 trillion through 2027 to pay for the corporate tax breaks,” says Bloomberg’s Mark Whitehouse. “So far, it’s hard to see what the country is getting in return.”
Chart of the Day: 2019’s Lobbying Leaders
Roll Call reports that trade, infrastructure and health care issues including prescription drug prices “dominated the lobbying agendas of some of the biggest spenders on K Street early this year.” Here’s Roll Call’s look at the top lobbying spenders so far this year:
Can You Fix Social Security? A New Tool Lets You Try
The Congressional Budget Office released an interactive tool Wednesday that shows how some widely discussed policy changes would affect the long-run financial health of the Social Security system.
“This interactive tool allows the user to explore seven policy options that could be used to improve the Social Security program’s finances and delay the trust funds’ exhaustion,” CBO said. “Four options would reduce benefits, and three options would increase payroll taxes. The tool allows for any combination of those options. It also lets the user change implementation dates and choose whether to show scheduled or payable benefits. … The tool also shows the impact of the options on different groups of people.”
Click here to view the interactive tool on the CBO website.
Why Prescription Drug Prices Keep Rising – and 3 Ways to Bring Them Down
Prescription drug prices have been rising at a blistering rate over the last few decades. Between 1980 and 2016, overall spending on prescription drugs rose from about $12 billion to roughly $330 billion, while its share of total health care spending doubled, from 5% to 10%.
Although lawmakers have shown renewed interest in addressing the problem, with pharmaceutical CEOs testifying before the Senate Finance Committee in February and pharmacy benefit managers (PBMS) scheduled to do so this week, no comprehensive plan to halt the relentless increase in prices has been proposed, let alone agreed upon.
Robin Feldman, a professor at the University of California Hastings College of Law, takes a look at the drug pricing system in a new book, “Drugs, Money and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices.” In a recent conversation with Bloomberg’s Joe Nocera, Feldman said that one of the key drivers of rising prices is the ongoing effort of pharmaceutical companies to maintain control of the market.
Fearing competition from lower-cost generics, drugmakers began over the last 10 or 15 years to focus on innovations “outside of the lab,” Feldman said. These innovations include paying PBMs to reduce competition from generics; creating complex systems of rebates to PBMs, hospitals and doctors to maintain high prices; and gaming the patent system to extend monopoly pricing power.
Feldman’s research on the dynamics of the drug market led her to formulate three general solutions for the problem of ever-rising prices:
1) Transparency: The current system thrives on secret deals between drug companies and middlemen. Transparency “lets competitors figure out how to compete and it lets regulators see where the bad behaviors occur,” Feldman says.
2) Patent limitations: Drugmakers have become experts at extending patents on existing drugs, often by making minor modifications in formulation, dosage or delivery. Feldman says that 78% of drugs getting new patents are actually old drugs gaining another round of protection, and thus another round of production and pricing exclusivity. A “one-and-done” patent system would eliminate this increasingly common strategy.
3) Simplification: Feldman says that “complexity breeds opportunity,” and warns that the U.S. “drug price system is so complex that the gaming opportunities are endless.” While “ruthless simplification” of regulatory rules and approval systems could help eliminate some of those opportunities, Feldman says that the U.S. doesn’t seem to be moving in this direction.
Read the full interview at Bloomberg News.